Article Information
History
- November 9, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Srinivas Shenoy1,
- Sagar Munjal2,
- Sarah Al Youha3,
- Mohammad Alghounaim4,
- Sulaiman Almazeedi5,
- Yousef Alshamali6,
- Richard H Kaszynski7,
- Salman Al-Sabah8,#,
- Kuwait Clinical Trial Group*
- 1Dr Reddy’s Laboratories Limited, 8-2-337, Road No.3, Banjara Hills, Hyderabad-500 034, India; Email: srinivasshenoyb{at}drreddys.com
- 2Dr Reddy’s Laboratories Limited, 8-2-337, Road No.3, Banjara Hills, Hyderabad-500 034, India; Email: munjalsagar{at}yahoo.com
- 3Jaber Al-Ahmad Al-Sabah Hospital, Kuwait, Khalid Ben AbdulAziz Street, South Surra-47781, Kuwait; Email: sarahalyouha{at}gmail.com
- 4Jaber Al Ahmad Hospital at Mishref Field Hospital, Mubarak Al-Abdullah Street, Mishref-90005, Kuwait; Email: mohammad.alghounaim{at}gmail.com
- 5Jaber Al Ahmad Hospital at Mishref Field Hospital, Mubarak Al-Abdullah Street, Mishref-90005, Kuwait; Email: al_mazeedi{at}yahoo.com
- 6Jaber Al Ahmad Hospital at Mishref Field Hospital, Mubarak Al-Abdullah Street, Mishref-90005, Kuwait; Email: yalshamali{at}moh.gov.kw
- 7Emergency and Critical Care Center, Tokyo Metropolitan Hiroo Hospital, 2-34-10, Ebisu, Shibuya-ku, Tokyo 150-0013, Japan; Email: rkaszynski.md.phd{at}gmail.com
- 8Jaber Al Ahmad Hospital at Mishref Field Hospital, Mubarak Al-Abdullah Street, Mishref-90005, Kuwait; Email: salman.k.alsabah{at}gmail.com
- ↵#Corresponding Author:
Salman Al-Sabah, Jaber Al-Ahmad Al-Sabah Hospital, Kuwait, Khalid Ben AbdulAziz Street, South Surra-47781, Kuwait. Email: salman.k.alsabah{at}gmail.com
Posted November 09, 2021.
Favipiravir In Adults with Moderate to Severe COVID-19: A Phase 3 Multicentre, Randomized, Double-Blinded, Placebo-Controlled Trial
